NeurologyLive, a print and digital information source for healthcare professionals treating neurological diseases, recently released a breakthrough in the study of ALS by PathMaker Neurosystems, of which College of Staten Island Professor Zaghloul Ahmed is the Scientific Founder.
According to NeurologyLive, “PathMaker Neurosystems has initiated a first-in-human study assessing its noninvasive neuromodulation device MyoRegulator in patients with amyotrophic lateral sclerosis (ALS).” Read the full story on the NeurologyLive Website.
